Targeting DNA methylation in cancer

There is overwhelming evidence that DNA methylation patterns are altered in cancer. Methylation of CG-rich islands in regulatory regions of genes marks them for transcriptional silencing. Multiple genes, which confer selective advantage upon cancer cells such as tumor suppressors, adhesion molecules, inhibitors of angiogenesis and repair enzymes are silenced. In parallel, tumor cell genomes are globally less methylated than their normal counterparts. In contrast to regional hypermethylation, this loss of methylation in cancer cells occurs in sparsely distributed CG sequences. We now understand that DNA methylation machineries might include a number of DNA methyltransferases, proteins that direct DNA methyltransferases to specific promoters, chromatin modifying enzymes as well as demethylases. There is also data to suggest that pharmacological down regulation of some members of the DNA methylation machinery could inhibit cancer in vitro, in vivo and in clinical trials. Understanding which functions of DNA methylation machinery are critical for cancer is essential for the design of inhibitors of the DNA methylation machinery as anticancer agents. This review discusses the possible role of DNA methyltranferases and demethylases in tumorigenesis and the possible pharmacological and therapeutic implications of the DNA methylation machinery.

[1]  M. Szyf,et al.  Regulation of DNA methylation by the Ras signaling pathway , 1995, The Journal of Biological Chemistry.

[2]  U. Weidle,et al.  Inhibition of histone deacetylases: a new strategy to target epigenetic modifications for anticancer treatment. , 2000, Anticancer research.

[3]  M. Szyf,et al.  Regulation of DNA Methylation in Human Breast Cancer , 2002, The Journal of Biological Chemistry.

[4]  M. Szyf,et al.  Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. Lenoir,et al.  MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland , 2002, Oncogene.

[6]  A. Bird,et al.  Identification and Characterization of a Family of Mammalian Methyl-CpG Binding Proteins , 1998, Molecular and Cellular Biology.

[7]  Gerd Ritter,et al.  Immunotherapeutic Targets Cancer : Identification of Potential Diagnostic and Cancer-related Serological Recognition of Human Colon Updated , 2002 .

[8]  S. Hirohashi,et al.  Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells. , 2002, Nucleic acids research.

[9]  W. Reik,et al.  Active demethylation of the paternal genome in the mouse zygote , 2000, Current Biology.

[10]  M. Szyf,et al.  Demethylase Activity Is Directed by Histone Acetylation* , 2001, The Journal of Biological Chemistry.

[11]  M. Szyf,et al.  Inhibition of DNA Methyltransferase Inhibits DNA Replication* , 2000, The Journal of Biological Chemistry.

[12]  M. D. De Miglio,et al.  Chemoprevention of hepatocarcinogenesis: S-adenosyl-L-methionine. , 2002, Alcohol.

[13]  J. Herman,et al.  Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer , 1999, Nature Genetics.

[14]  A. Bird,et al.  Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. , 2001, Genes & development.

[15]  Z. Paroush,et al.  Dynamics of demethylation and activation of the α-actin gene in myoblasts , 1990, Cell.

[16]  J. Seidman,et al.  Nucleotide-sequence-specific de novo methylation in a somatic murine cell line. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Herman,et al.  Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Siegmann,et al.  5-methylcytosine-DNA glycosylase activity is present in a cloned G/T mismatch DNA glycosylase associated with the chicken embryo DNA demethylation complex. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Ehrlich,et al.  DNA methylation in cancer: too much, but also too little , 2002, Oncogene.

[20]  S. Baylin,et al.  DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci , 2000, Nature Genetics.

[21]  A. Bird,et al.  MeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin , 1997, Cell.

[22]  D. Scherman,et al.  Antisense MBD2 gene therapy inhibits tumorigenesis , 2002, The journal of gene medicine.

[23]  M. Szyf,et al.  A Conserved 3′-Untranslated Element Mediates Growth Regulation of DNA Methyltransferase 1 and Inhibits Its Transforming Activity* , 2001, The Journal of Biological Chemistry.

[24]  A. Riggs,et al.  DNA methylation and gene function. , 1980, Science.

[25]  D. Santi,et al.  On the mechanism and inhibition of DNA cytosine methyltransferases. , 1985, Progress in clinical and biological research.

[26]  M. Robert,et al.  An Essential Role for DNA Methyltransferase DNMT3B in Cancer Cell Survival* , 2002, The Journal of Biological Chemistry.

[27]  Gangning Liang,et al.  Cooperativity between DNA Methyltransferases in the Maintenance Methylation of Repetitive Elements , 2002, Molecular and Cellular Biology.

[28]  A. Macleod,et al.  Down-regulation of Human DNA-(Cytosine-5) Methyltransferase Induces Cell Cycle Regulators p16 ink4A and p21WAF/Cip1 by Distinct Mechanisms* , 1999, The Journal of Biological Chemistry.

[29]  S. Baylin,et al.  Increased cytosine DNA-methyltransferase activity during colon cancer progression. , 1993, Journal of the National Cancer Institute.

[30]  S Ramchandani,et al.  DNA methylation is a reversible biological signal. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Szyf,et al.  The Oncoprotein Set/TAF-1β, an Inhibitor of Histone Acetyltransferase, Inhibits Active Demethylation of DNA, Integrating DNA Methylation and Transcriptional Silencing* , 2002, The Journal of Biological Chemistry.

[32]  D. Haber,et al.  DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.

[33]  H. Ng,et al.  Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. , 1997, Science.

[34]  F. Kaye,et al.  CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2'deoxycytidine. , 1995, Oncogene.

[35]  M. Szyf,et al.  A mammalian protein with specific demethylase activity for mCpG DNA , 1999, Nature.

[36]  H. Cedar,et al.  Effect of regional DNA methylation on gene expression. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[37]  P. Marks,et al.  Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. , 2000, Journal of the National Cancer Institute.

[38]  P. Laird,et al.  CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. , 1999, Cancer research.

[39]  M. Siegmann,et al.  Overexpression of 5-methylcytosine DNA glycosylase in human embryonic kidney cells EcR293 demethylates the promoter of a hormone-regulated reporter gene , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Potter.  Methyl supply, methyl metabolizing enzymes and colorectal neoplasia. , 2002, The Journal of nutrition.

[41]  L. Poirier.  The effects of diet, genetics and chemicals on toxicity and aberrant DNA methylation: an introduction. , 2002, The Journal of nutrition.

[42]  M. Szyf.  The DNA methylation machinery as a target for anticancer therapy. , 1996, Pharmacology & therapeutics.

[43]  A. Bird.  CpG-rich islands and the function of DNA methylation , 1986, Nature.

[44]  T. Meitinger,et al.  DNA, FISH and complementation studies in ICF syndrome: DNA hypomethylation of repetitive and single copy loci and evidence for a trans acting factor , 1995, Human Genetics.

[45]  Peter L. Jones,et al.  DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters , 2000, Nature Genetics.

[46]  R. Dahiya,et al.  DNA methyltransferase and demethylase in human prostate cancer , 2002, Molecular carcinogenesis.

[47]  S. Minucci,et al.  Methyltransferase Recruitment and DNA Hypermethylation of Target Promoters by an Oncogenic Transcription Factor , 2002, Science.

[48]  E. Selker,et al.  A histone H3 methyltransferase controls DNA methylation in Neurospora crassa , 2001, Nature.

[49]  S. Hirohashi,et al.  Reduced mRNA expression of the DNA demethylase, MBD2, in human colorectal and stomach cancers. , 1999, Biochemical and biophysical research communications.

[50]  R. Jaenisch,et al.  Dnmt1 Overexpression Causes Genomic Hypermethylation, Loss of Imprinting, and Embryonic Lethality , 2002, Molecular and Cellular Biology.

[51]  M. Szyf,et al.  Replacement of 5-methylcytosine by cytosine: a possible mechanism for transient DNA demethylation during differentiation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[52]  M. Szyf,et al.  Modified Oligonucleotides as Bona Fide Antagonists of Proteins Interacting with DNA , 1999, The Journal of Biological Chemistry.

[53]  C. Allis,et al.  The language of covalent histone modifications , 2000, Nature.

[54]  John G. Collard,et al.  Induction of invasive and metastatic potential in mouse T-lymphoma cells (BW5147) by treatment with 5-azacytidine , 1990, Clinical & Experimental Metastasis.

[55]  K. Takenaga.  Modification of the metastatic potential of tumor cells by drugs , 2004, Cancer and Metastasis Reviews.

[56]  M. Szyf,et al.  Promoter-specific Activation and Demethylation by MBD2/Demethylase* , 2002, The Journal of Biological Chemistry.

[57]  A. Feinberg,et al.  Hypomethylation of ras oncogenes in primary human cancers. , 1983, Biochemical and biophysical research communications.

[58]  J. Strouboulis,et al.  Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription , 1998, Nature Genetics.

[59]  R J Roberts,et al.  AdoMet-dependent methylation, DNA methyltransferases and base flipping. , 2001, Nucleic acids research.

[60]  H. Leonhardt,et al.  A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei , 1992, Cell.

[61]  Peter A. Jones.  Altering gene expression with 5-azacytidine , 1985, Cell.

[62]  M. Siegmann,et al.  5-Methylcytosine DNA glycosylase activity is also present in the human MBD4 (G/T mismatch glycosylase) and in a related avian sequence. , 2000, Nucleic acids research.

[63]  Howard Cedar,et al.  A role for nuclear NF–κB in B–cell–specific demethylation of the Igκ locus , 1996, Nature Genetics.

[64]  A. Razin,et al.  Distribution of 5-methylcytosine in chromatin. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[65]  M. Ehrlich,et al.  DNA demethylation and pericentromeric rearrangements of chromosome 1. , 1997, Mutation research.

[66]  A. Marzo,et al.  Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. , 1999, Cancer research.

[67]  C. Hsieh,et al.  Modulation of DNA Binding Protein Affinity Directly Affects Target Site Demethylation , 2000, Molecular and Cellular Biology.

[68]  H. Sakamoto,et al.  DNA Demethylase Expression Correlates with Lung Resistance Protein Expression in Common Epithelial Ovarian Cancers , 2001, The Journal of international medical research.

[69]  C. Wijmenga,et al.  The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[70]  M. Szyf,et al.  DNA Methyltransferase Inhibition Induces the Transcription of the Tumor Suppressor p21 WAF1/CIP1/sdi1 * , 2000, The Journal of Biological Chemistry.

[71]  M. Szyf,et al.  DNA methylation patterns. Formation and function. , 1984, Biochimica et biophysica acta.

[72]  M. Siegmann,et al.  Mechanisms of DNA Demethylation in Chicken Embryos , 1995, The Journal of Biological Chemistry.

[73]  Paul Tempst,et al.  MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex , 1999, Nature Genetics.

[74]  M. Szyf.  DNA methylation patterns: an additional level of information? , 1991, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[75]  R. Weinberg,et al.  Suppression of intestinal neoplasia by DNA hypomethylation , 1995, Cell.

[76]  M. Ehrlich.  DNA hypomethylation, cancer, the immunodeficiency, centromeric region instability, facial anomalies syndrome and chromosomal rearrangements. , 2002, Journal of NutriLife.

[77]  R J Roberts,et al.  Recombinant Human DNA (Cytosine-5) Methyltransferase , 1999, The Journal of Biological Chemistry.

[78]  J. Minna,et al.  The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14ARF, p16INK4a and RASSF1A in human lung cancer cell lines , 2002, Oncogene.

[79]  S. Baylin,et al.  De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase , 1996, Molecular and cellular biology.

[80]  M. Szyf,et al.  Towards a pharmacology of DNA methylation. , 2001, Trends in pharmacological sciences.

[81]  M. Szyf,et al.  The DNMT1 Target Recognition Domain Resides in the N Terminus* , 2001, The Journal of Biological Chemistry.

[82]  E. Li,et al.  DNA methyltransferase in normal and Dnmtn/Dnmtn mouse embryos , 1996, Developmental dynamics : an official publication of the American Association of Anatomists.

[83]  Rudolf Jaenisch,et al.  DNA hypomethylation leads to elevated mutation rates , 1998, Nature.

[84]  E. Selker.  Trichostatin A causes selective loss of DNA methylation in Neurospora. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[85]  G. Satta,et al.  Reversal by 5-azacytidine of the S-adenosyl-L-methionine-induced inhibition of the development of putative preneoplastic foci in rat liver carcinogenesis. , 1991, Cancer letters.

[86]  A. Feinberg,et al.  Limited up-regulation of DNA methyltransferase in human colon cancer reflecting increased cell proliferation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[87]  P. Laird,et al.  Hypomethylation and hypermethylation of DNA in Wilms tumors , 2002, Oncogene.

[88]  Luke Hughes-Davies,et al.  DNA methyltransferase Dnmt1 associates with histone deacetylase activity , 2000, Nature Genetics.

[89]  Colin A. Johnson,et al.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.

[90]  Matthew Tudor,et al.  Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation , 2001, Nature Genetics.

[91]  M. Szyf,et al.  Genomic structure of the human DNA methyltransferase gene. , 1998, Biological chemistry.

[92]  A. Bird,et al.  Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. , 1999, Genes & development.

[93]  M. Szyf,et al.  Cellular and viral DNA hypomethylation associated with induction of Epstein-Barr virus lytic cycle. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[94]  M. Comb,et al.  CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2 , 1990, Nucleic Acids Res..

[95]  J. Herman,et al.  DNA hypermethylation in tumorigenesis: epigenetics joins genetics. , 2000, Trends in genetics : TIG.